Mark Mallon
Chief Executive Officer en NeoGenomics Laboratories, Inc. .
Perfil
El Sr. Mark Mallon es director general y consejero de NeoGenomics Laboratories, Inc. y director general y consejero de NeoGenomics, Inc. Es miembro del Consejo de Administración de NeoGenomics Laboratories, Inc. y de NeoGenomics, Inc. Anteriormente, el Sr. Mallon fue director general y consejero de Ironwood Pharmaceuticals, Inc., presidente de Astrazeneca China Ltd., director de operaciones de Astrazeneca Japan Ltd., vicepresidente de operaciones de marketing y ventas de AstraZeneca Pharmaceuticals LP y vicepresidente ejecutivo internacional de AstraZeneca Plc. También formó parte del consejo de administración de Christiana Care Corp. Se licenció en la Universidad de Pensilvania y obtuvo un MBA en la Wharton School de la Universidad de Pensilvania.
Cargos activos de Mark Mallon
| Empresas | Cargo | Inicio |
|---|---|---|
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Chief Executive Officer | 19/04/2021 |
Antiguos cargos conocidos de Mark Mallon.
| Empresas | Cargo | Fin |
|---|---|---|
| NEOGENOMICS, INC. | Chief Executive Officer | 28/03/2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Chief Executive Officer | 12/03/2021 |
| Astrazeneca China Ltd. | President | 01/11/2011 |
Astrazeneca Japan Ltd.
 Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Chief Operating Officer | 01/04/2011 |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | President | - |
Formación de Mark Mallon.
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NEOGENOMICS, INC. | Health Services |
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Part of AstraZeneca PLC, Astrazeneca Japan Ltd. is a science-oriented bio and Japanese pharmaceutical company. The private company is based in Ofuka-cho, Japan. Astrazenka mainly focuses on oncology, cardiovascular, metabolism/gastrointestinal diseases, and respiratory diseases to further contribute to the development of patients' health and medical care. The CEO of the company is Stephen Voxstram. | Health Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services NeoGenomics Laboratories, Inc. operates as a cancer diagnostics and pharma services company. It serves oncologists, pathologists, pharmaceutical companies, academic centers, and others with diagnostic, prognostic and predictive testing. The company was founded in 2002 and is headquartered in Fort Myers, FL. | Health Services |
| Astrazeneca China Ltd. | |
Christiana Care Corp.
 Christiana Care Corp. Hospital/Nursing ManagementHealth Services Christiana Care Corp. operates as a healthcare organization. The private company is based in Middletown, DE. | Health Services |
- Bolsa de valores
- Insiders
- Mark Mallon
